Delivery Order SPE2DB22D1106-SPE2DB24FFHX6

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $2,331.48 firm-fixed-price delivery order is for the supply of 4,564,614,851 units of Focalin XR 15 mg capsules. The contract has an ultimate completion date of May 14, 2024 and was awarded on May 13, 2024. This order is not set aside for any specific business type. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,162.72 firm fixed-price delivery order is for the supply of 4,566,054,317 units of the prescription medication Focalin XR 15 mg capsules. The contract has an ultimate completion date of October 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded this delivery order as well as multiple...
This federal contract award, with the ID SPE2DB22D1103|SPE2DB24FTQP4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,374.63 firm-fixed-price delivery order is for the supply of 4,565,561,918 units of the pharmaceutical product Focalin XR 30 mg capsules. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded this contract to provide...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,956,800 units of Focalin XR 15 mg capsules. The firm-fixed-price delivery order, valued at $1,855.32, has a period of performance running through March 14, 2024. The contract does not have a set-aside designation, indicating open competition. As a large pharmaceutical supplier, AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,615.08 firm fixed price delivery order is for the supply of 4,565,256,356 units of Focalin XR 30 mg capsules. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Focalin XR 30 mg capsules to support the Medical Supply Chain of the Defense Logistics Agency (DLA). The $5,105.72 firm-fixed-price delivery order has a completion date of September 12, 2024 and is not set aside for any particular business type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,380.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Focalin XR 15 mg capsules. It is a firm fixed price delivery order with a completion date of January 30, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, which is not designated...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense-focused agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,530.04 firm fixed price delivery order is for the supply of 4,564,478,173 units of the medication Focalin XR 25 mg capsules. The order has a completion date of May 3, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for 4,564,220,371 units of Focalin XR 10 mg capsules, with a ceiling value of $3,184.60 and an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,413.84 firm fixed-price delivery order is for the supply of FOCALIN XR 30 MG CAPSULES with an ultimate completion date of January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFHX6
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,785.04 firm fixed-price delivery order is for the supply of 4,565,536,643 units of Focalin XR 30 mg capsules. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen is a major pharmaceutical distributor and has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other agencies to provide a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, to support federal healthcare programs. This contract award does not appear to have a set-aside designation.

Generated 11/20/24, 9:08 AM